Anti-cancer therapy related hand-foot syndrome in patients with systemic sclerosis: Case series and literature review
Hand-foot syndrome (HFS) is a common chemotherapy side effect, typically managed with supportive care including preemptive cooling. Systemic sclerosis (SSc) is an autoimmune disease characterized by vascular dysfunction and fibrosis of multiple organs, including the hands, which can result in acro-o...
Main Authors: | Madison Grinnell, Kerri E. Rieger, Tamiko R. Katsumoto, Bernice Y. Kwong, Lisa C. Zaba |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Current Problems in Cancer: Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666621920300211 |
Similar Items
-
The Effect of Captopril Added to Standard Chemotherapy Regimen Containing Capecitabine in the Prevention of Hand and Foot Syndrome in Patients with Colorectal Cancer
by: Mahnaz Roayaei, et al.
Published: (2019-10-01) -
Corrigendum to “Anti-Cancer Therapy Related Hand-Foot Syndrome in Patients with Systemic Sclerosis: Case Series and Literature Review” [Current Problems in Cancer: Case Reports 1C (2020)]
by: Madison Grinnell, et al.
Published: (2021-03-01) -
Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer
by: Shaoyan Lin, et al.
Published: (2019-10-01) -
Peculiar acral and oral pigmentation after docetaxel therapy: An unresolved dilemma
by: Guneet Awal, et al.
Published: (2018-01-01) -
Effectiveness of protocol-based pharmacotherapy management collaboration between hospital and community pharmacists to address capecitabine-related hand–foot syndrome in cancer patients: a retrospective study
by: Nobuhiko Nakamura, et al.
Published: (2021-03-01)